Course of psychiatric symptoms and global cognition in early Parkinson disease

Neurology

Volumn 83, Issue 12, 2014, Pages 1096-1103

  De La Riva, Patricia ^a   Smith, Kara ^a,c   Xie, Sharon X ^b   Weintraub, Daniel ^b,d  

^a HOSPITAL DONOSTIA   (Spain)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; MONOAMINE OXIDASE B INHIBITOR;

ADULT; ANXIETY; APATHY; ARTICLE; ASSESSMENT OF HUMANS; COGNITION; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DAYTIME SOMNOLENCE; DEPRESSION; FATIGUE; FEMALE; FOLLOW UP; HUMAN; IMPULSE CONTROL DISORDER; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MONTREAL COGNITIVE ASSESSMENT; PARKINSON DISEASE; PARKINSON PROGRESSION MARKERS INITIATIVE; PRIORITY JOURNAL; PSYCHOSIS; SAMPLE SIZE; SCREENING; SLEEP; SUBSTITUTION THERAPY; TREATMENT DURATION; WAKEFULNESS; AGED; CASE CONTROL STUDY; COGNITIVE DEFECT; COMPLICATION; DISEASE COURSE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; SLEEP DISORDER; STATISTICAL MODEL;

AGED; ANXIETY; APATHY; CASE-CONTROL STUDIES; COGNITION DISORDERS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DEPRESSION; DISEASE PROGRESSION; FATIGUE; FEMALE; HUMANS; IMPULSE CONTROL DISORDERS; LINEAR MODELS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PSYCHOTIC DISORDERS; SEVERITY OF ILLNESS INDEX; SLEEP DISORDERS;

EID: 84922234921     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000801     Document Type: Article

References (38)

1. Weintraub D, Stern MB. Psychiatric complications in Parkinson's disease. Am J Geriatr Psychiatry 2005;13: 844-851.
2. Aarsland D, Brønnick K, Alves G, et al. The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson's disease. J Neurol Neurosurg Psychiatry 2009;80:928-930.
3. Chaudhuri K, Healy D, Schapira A. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 2006;5:235-245.
4. Aarsland D, Bronnick K, Williams-Gray CH, et al. Mild cognitive impairment in Parkinson's disease: a multicenter pooled analysis. Neurology 2010;75:1062-1069.
5. Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sørensen P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 2003; 60:387-392.
6. Khoo TK, Yarnall AJ, Duncan GW, et al. The spectrum of nonmotor symptoms in early Parkinson disease. Neurology 2013;80:276-281.
7. Poletti M, Frosini D, Pagni C, et al. Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2012;83:601-606.
8. Broeders M, De Bie RMA, Velseboer DC, Speelman JD, Muslimovic D, Schmand B. Evolution of mild cognitive impairment in Parkinson disease. Neurology 2013;81: 346-352.
9. Yarnall A, Breen D, Duncan G, et al. Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD Study. Neurology 2014;82:1-9.
10. Marek K, Jennings D, Lasch S, et al. The Parkinson Progression Marker Initiative (PPMI). Prog Neurobiol 2011; 95:629-635.
11. Weintraub D, Oehlberg KA, Katz IR, Stern MB. Test characteristics of the 15-Item geriatric depression scale and Hamilton depression rating scale in Parkinson disease. Am J Geriatr Psychiatry 2006;14:169-175.
12. Dalrymple-Alford J, MacAskill M, Nakas C, et al. The MoCA: well-suited screen for cognitive impairment in Parkinson disease. Neurology 2010;75:1717-1725.
13. Nasreddine ZS, PhillipsNA, Bédirian V, et al.The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695-699.
14. Weintraub D, Stewart S, Shea JA, et al. Validation of the Questionnaire for Impulsive-Compulsive Behaviors in Parkinson's Disease (QUIP). Mov Disord 2009;24: 1461-1467.
15. Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991;14:540-545.
16. Spielberger CD, Gorsuch RL, Lushene RE. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press; 1970.
17. Doty RL, Shaman P, Dann M. Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol Behav 1984;32:489-502.
18. Stiasny-Kolster K, Mayer G, Schäfer S, Möller JC, Heinzel-Gutenbrunner M, Oertel WH. The REM sleep behavior disorder screening questionnaire-a new diagnostic instrument. Mov Disord 2007;22:2386-2393.
19. Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and climimetric testing results. Mov Disord 2008; 23:2129-2170.
20. Kang JH, Irwin DJ, Chen-Plotkin AS, et al. Association of cerebrospinal fluid b-amyloid 1-42, T-tau, P-tau182, and a-synuclein levels with clinical features of drug-naive patients with early Parkinson disease. JAMA Neurol 2013; 70:1277-1287.
21. Burn D, Rowan E, Allan L, Molloy S, O'Brien J, McKeith I. Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 2006;77:585-589.
22. Zeger SL, Liang K-Y, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics 1988;44:1049-1060.
23. Laird NM, Ware JH. Random effects models for longitudinal data. Biometrics 1982;38:963-997.
24. Remy P, Doder M, Lees A, Turjanski N, Brooks D. Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 2005;128:1314-1322.
25. Weintraub D, Koester J, Potenza MN, et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 2010;67:589-595.
26. Burn DJ, Tröster AI. Neuropsychiatric complications of medical and surgical therapies for Parkinson's disease. J Geriatr Psychiatry Neurol 2004;17:172-180.
27. Ardouin C, Chereau I, Llorca P, et al. Assessment of hyper-and hypodopaminergic behaviors in Parkinson's disease. Rev Neurol 2009;175:845-856.
28. Barone P, Poewe W, Albrecht S, et al. Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2010;9:573-580.
29. Weintraub D, Papay K, Siderowf A, Screening for impulse control disorder symptoms in patients with de novo Parkinson disease: a case-control study. Neurology 2013;80:176-180.
30. Evans JR, Mason SL, Williams-Gray CH, et al. The natural history of treated Parkinson's disease in an incident, community based cohort. J Neurol Neurosurg Psychiatry 2011;82:1112-1118.
31. Vendette M, Gagnon J-F, Dècary A, et al. REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia. Neurology 2007; 69:1843-1849.
32. Alves G, Larsen JP, Emre M, Wentzel-Larsen T, Aarsland D. Changes in motor subtype and risk for incident dementia in Parkinson's disease. Mov Disord 2006;21:1123-1130.
33. Baba T, Kikuchi A, Hirayama K, et al. Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson's disease: a 3-year longitudinal study. Brain 2012;135:161-169.
34. Boot B, Boeve B, Roberts R, et al. Probable rapid eye movement sleep behavior disorder increases risk for mild cognitive impairment and Parkinson disease: a populationbased study. Ann Neurol 2012;71:49-56.
35. Williams-Gray CH, Foltynie T, Brayne CEG, Robbins TW, Barker RA. Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain 2007; 130:1787-1798.
36. Weintraub D, Moberg PJ, Duda JE, Katz IR, Stern MB. Recognition and treatment of depression in Parkinson's disease. J Geriatr Psychiatry Neurol 2003; 16:178-183.
37. Shulman LM, Taback RL, Rabinstein AA, et al. Nonrecognition of depression and other non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord 2002;8:193-197.
38. Ravina B, Camicioli R, Como PG, et al. The impact of depressive symptoms in early Parkinson disease. Neurology 2007;69:342-347.